| Ticker | GKOS |
|---|---|
| ISIN | US3773221029 |
| Sector | Atención sanitaria |
| Mercado | NYSE |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standal...
Glaukos Corporation opera en el sector Healthcare, industria Medical - Devices.